Research context
What has been studied.
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗SR9011 is a small-molecule research product rather than a peptide.
Also known as sr-9011
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
No offer meets every pick rule today. The exact-product comparisons below still list every recorded price.
Same format. Same amount.
0 of 1 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: SR9011 COAs →
What it is
SR-9011 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the viability of normal cells or tissues. The listed molecular formula is C23H31ClN4O3S. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
SR9011 is commonly sold or discussed for a range of compound-specific research goals. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Swiss Chems | Grade C | 1 | 1 | $49.99 · 5 mg capsule · pack of 60Observed Nov 14, 2026 |
| Next Chems | Not graded | 1 | 1 | $85.95 · 5 mg capsule · pack of 60Observed Nov 14, 2026 |
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.